tirzepatide injection areas How to Inject Your Semaglutide/Tirzepatide (GLP-1 Analogs) Mounjaro (Tirzepatide) for Medical Weight

2012;19:F77-88

As we did not observe any discontinuation of treatment during the study period, it remains unclear whether pwIIH successfully treated with GLP-1-RAs sustain their weight loss, or a yo-yo effect occurs [44], which would pose an increased risk for a disease relapse

doi:10.1016/j.bcp.2015.07.012 Zhao JV, Yeung WF, Chan YH, et al

The news: Novo Nordisks GLP-1 drug semaglutide failed to slow the progression of Alzheimers disease in new study results, dimming hopes that GLP-1s might be approved to treat the condition

NHS access is likely to be available from 2029 at the earliest, and only if NICE finds it cost-effective

doi: 10.1038/ncpendmet1066